Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI South Korea ETF (EWY) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

iShares MSCI South Korea ETFTrade
Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI South Korea ETF vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? iShares MSCI South Korea ETF trades at $149.85 (market cap $22.66B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: iShares MSCI South Korea ETF is far larger — about 3.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and iShares MSCI South Korea ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI South Korea ETF for 48 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

EWYIONS
Market Cap
$22.66B$7.10B
Volume
17,900,4002,027,457
Sector
Broad Market / FactorHealth
52-Week High
$219.20$86.50
52-Week Low
$85.17$42.38
Typical Hold Time
48 Days0 Days
Enterprise Value
—$6.66B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI South Korea ETF

EWY, the iShares MSCI South Korea ETF, trades at $166.56, down 2.16% amid broader Asian market pressures from rising oil prices and U.S. bond yields. Technical indicators show a bearish trend with strong selling signals from moving averages and oscillators, though RSI levels suggest potential oversold conditions. The ETF remains heavily concentrated in semiconductor giants Samsung and SK hynix, benefiting from AI-driven memory demand but vulnerable to sector volatility.

Outlook hinges on AI infrastructure spending and memory cycle strength, with corporate earnings showing resilience. Risks include high concentration in two stocks, geopolitical tensions, and sensitivity to global interest rates. Near-term support at $166 could test investor confidence if macroeconomic pressures persist.

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWY
43% Buy57% Sell
Avg holding period · 48 Days
IONS
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About iShares MSCI South Korea ETF

EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.

Read more on EWY →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →